Updated AHA and ASA guidelines emphasize interprofessional care and inpatient rehabilitation facilities for poststroke recovery.
In this analysis, 214 U.S. patients received the recently approved RYBREVANT FASPRO plus LAZCLUZE regimen with prophylactic strategies to reduce the risk of blood clots with oral anticoagulation and ...
IV–V brain arteriovenous malformations (bAVMs) remains controversial. This study evaluates the safety and effectiveness of ...
HF with mildly reduced EF is gone, stages are updated, and new classifications for medical and interventional therapies are ...
Investigators stressed that the method is simple, doesn’t require ultrasound, and can be done with existing cath lab ...
Terminology shifts to “decompensated heart failure,” introducing an initial–stabilization–pre/postdischarge framework and ...
Positive results from the DESTINY-Lung04 Phase III trial showed AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically ...
Despite notable advancements in the acute and long-term management, coronary artery disease and myocardial infarction (MI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results